Sun Pharmaceutical rises as its arm launches CEQUA for Canadians living with dry eye disease

sun pharma launches drizalma sprinkle in us

Sun Pharmaceutical Industries is currently trading at Rs. 813.15, up by 6.15 points or 0.76% from its previous closing of Rs. 807.00 on the BSE. The scrip opened at Rs. 806.40 and has touched a high and low of Rs. 817.05 and Rs. 791.30 respectively. So far 78715 shares were traded on the counter. The … Read more

Sun Pharma slips on recalling products in US market

sun pharma launches drizalma sprinkle in us

Sun Pharmaceutical Industries is currently trading at Rs. 602.40, down by 2.95 points or 0.49% from its previous closing of Rs. 605.35 on the BSE. The scrip opened at Rs. 606.05 and has touched a high and low of Rs. 610.00 and Rs. 602.00 respectively. So far 50903 shares were traded on the counter. The … Read more

SPARC collaborates with HitGen

Sun Pharma Advanced Research Company (SPARC) and HitGen have collaborated to identify novel small molecule leads for targets of interest. Under this collaboration, HitGen will apply its advanced technology platform, based on DNA-encoded library design, synthesis and screening, to discover novel leads for SPARC. Under the terms of the agreement, HitGen will receive upfront payment … Read more